Andrew B Epstein, MD
Urology · Mountain View
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 13
- 1 carrier
- Office
- 1
Offices
1 location
Looking this up.
Plans that list them
13 plans · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Epstein’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Sutter Advantage +More (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
California Medical Board record
Licence A46519 · Current
Licensed to practise in California · since 1989 · expires 2028-10-31 · University of Arizona College of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Original Medicare doctor bills
$4,632
Medicare paid this office $4,632 for 22 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
Procedures Medicare counted
| Prostate resection | 1-10 | None |
Who their Medicare patients are
22 Original Medicare patients in 2024. Average age 75 · Health risk score 1.33. At or below the middle of the specialty; the typical urology clinician is at 1.36.
Conditions among them: High blood pressure 75% · Coronary heart disease 55%.
The office billed $30,282, Medicare allowed $5,807 and paid $4,632; for 28 services of 20 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 22 | 28 | 75 | 1.33 | $30,282 | $4,632 |
| 2023 | 38 | 50 | 77 | 1.68 | $46,830 | $6,654 |
| 2022 | 50 | 56 | 77 | 1.13 | $51,331 | $8,309 |
| 2021 | 40 | 56 | 76 | 1.20 | $49,280 | $7,035 |
| 2020 | 46 | 885 | 78 | 1.36 | $35,110 | $7,168 |
| 2019 | 249 | 763 | 78 | 1.37 | $249,412 | $46,873 |
| 2018 | 561 | 5,107 | 77 | 1.12 | $831,940 | $177,328 |
| 2017 | 503 | 3,392 | 76 | 1.13 | $817,763 | $182,242 |
| 2016 | 518 | 1,803 | 76 | 1.05 | $737,276 | $160,045 |
| 2015 | 557 | 1,975 | 76 | 0.99 | $846,754 | $172,209 |
| 2014 | 572 | 1,731 | 76 | 0.98 | $881,477 | $169,380 |
| 2013 | 489 | 1,622 | 75 | 0.98 | $878,212 | $160,175 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2022: 1 service
| Removal of blood clot and portion of chest, neck, or brain artery | 16 | $2,425 | $152 |
2021: 1 service
| Removal of blood clot and portion of chest, neck, or brain artery | 14 | $2,152 | $154 |
2020: 1 service
| Short return visit (20+ min) | 11 | $797 | $72 |
2019: 10 services
| Short return visit (20+ min) | 112 | $6,417 | $52 |
| Insertion of lower leg neurostimulator electrode | 21 | $5,089 | $121 |
| Diagnostic exam of bladder and urethra using an endoscope | 27 | $3,735 | $129 |
| Return visit (30+ min) | 39 | $3,122 | $80 |
| New patient visit (30+ min) | 32 | $2,618 | $82 |
| Ultrasound scan of pelvic region through rectum | 12 | $1,538 | $128 |
| Ultrasound measurement of bladder capacity after voiding | 68 | $884 | $12 |
| Injection of drug or substance under skin or into muscle | 19 | $401 | $15 |
| Automated urinalysis test | 66 | $188 | $2 |
| Injection, garamycin, gentamicin, up to 80 mg | 13 | $23 | None |
2018: 16 services
| Leuprolide acetate (for depot suspension), 7.5 mg | 20 | $28,215 | None |
| Short return visit (20+ min) | 278 | $26,366 | $62 |
| New patient visit (30+ min) | 203 | $18,368 | $90 |
| Insertion of lower leg neurostimulator electrode | 30 | $18,365 | $131 |
| Diagnostic exam of bladder and urethra using an endoscope | 73 | $13,313 | $146 |
| Return visit (30+ min) | 99 | $9,643 | $89 |
| Biopsy of prostate gland | 22 | $5,552 | $241 |
| Complicated insertion of bladder tube | 15 | $4,220 | $117 |
| Ultrasound measurement of bladder capacity after voiding | 183 | $4,015 | $16 |
| Ultrasound scan of pelvic region through rectum | 35 | $3,487 | $94 |
| New patient visit (45+ min) | 16 | $2,417 | $151 |
| Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | 21 | $1,381 | $31 |
| Injection of drug or substance under skin or into muscle | 43 | $1,170 | $21 |
| Automated urinalysis test | 131 | $434 | $3 |
| Urinalysis, manual test | 40 | $143 | $3 |
| Injection, garamycin, gentamicin, up to 80 mg | 46 | $68 | None |
2017: 19 services
| Leuprolide acetate (for depot suspension), 7.5 mg | 21 | $27,688 | None |
| Short return visit (20+ min) | 267 | $25,717 | $61 |
| New patient visit (30+ min) | 163 | $14,515 | $89 |
| Diagnostic exam of bladder and urethra using an endoscope | 78 | $14,291 | $150 |
| Insertion of lower leg neurostimulator electrode | 27 | $9,160 | $122 |
| Return visit (30+ min) | 82 | $8,318 | $95 |
| Ultrasound measurement of bladder capacity after voiding | 166 | $4,057 | $19 |
| Biopsy of prostate gland | 16 | $3,664 | $229 |
| Complicated insertion of bladder tube | 13 | $3,406 | $114 |
| Ultrasound scan of pelvic region through rectum | 31 | $2,929 | $89 |
| New patient visit (45+ min) | 16 | $2,329 | $146 |
| Injection of drug or substance under skin or into muscle | 46 | $1,575 | $25 |
| Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | 22 | $1,387 | $33 |
| Ultrasonic guidance for needle placement | 15 | $1,060 | $59 |
| Simple bladder irrigation and/or instillation | 15 | $907 | $48 |
| Automated urinalysis test | 95 | $377 | $3 |
| Manual urinalysis test with examination using microscope, automated | 68 | $294 | $4 |
| Injection, garamycin, gentamicin, up to 80 mg | 42 | $85 | None |
| Urinalysis, manual test | 21 | $70 | $3 |
2016: 17 services
| Leuprolide acetate (for depot suspension), 7.5 mg | 20 | $26,171 | None |
| Short return visit (20+ min) | 267 | $23,441 | $59 |
| Diagnostic exam of bladder and urethra using an endoscope | 97 | $21,056 | $186 |
| New patient visit (30+ min) | 150 | $13,965 | $93 |
| Insertion of lower leg neurostimulator electrode | 27 | $10,698 | $127 |
| Return visit (30+ min) | 90 | $9,515 | $94 |
| Ultrasound measurement of bladder capacity after voiding | 176 | $4,178 | $18 |
| Complicated insertion of bladder tube | 11 | $3,111 | $120 |
| New patient visit (45+ min) | 21 | $2,864 | $136 |
| Simple bladder irrigation and/or instillation | 20 | $1,608 | $67 |
| Ultrasound scan of pelvic region through rectum | 13 | $1,235 | $95 |
| Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | 20 | $1,105 | $32 |
| Injection of drug or substance under skin or into muscle | 31 | $915 | $25 |
| Ultrasonic guidance for needle placement | 11 | $649 | $59 |
| Manual urinalysis test with examination using microscope, automated | 77 | $347 | $4 |
| Automated urinalysis test | 87 | $314 | $3 |
| Injection, garamycin, gentamicin, up to 80 mg | 29 | $33 | None |
2015: 20 services
| Leuprolide acetate (for depot suspension), 7.5 mg | 18 | $26,867 | None |
| Short return visit (20+ min) | 277 | $26,576 | $65 |
| Diagnostic exam of bladder and urethra using an endoscope | 103 | $25,146 | $196 |
| New patient visit (30+ min) | 206 | $18,836 | $91 |
| Return visit (30+ min) | 67 | $6,830 | $98 |
| Insertion of lower leg neurostimulator electrode | 18 | $4,714 | $127 |
| Ultrasound measurement of bladder capacity after voiding | 187 | $4,403 | $19 |
| Ultrasound scan of pelvic region through rectum | 31 | $2,998 | $97 |
| Biopsy of prostate gland | 12 | $2,488 | $207 |
| New patient visit (45+ min) | 15 | $2,299 | $153 |
| Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | 18 | $1,237 | $34 |
| Simple insertion of temporary bladder tube | 11 | $1,202 | $67 |
| Injection of drug or substance under skin or into muscle | 34 | $1,117 | $24 |
| Ultrasonic guidance for needle placement | 12 | $852 | $61 |
| Simple bladder irrigation and/or instillation | 11 | $797 | $61 |
| Insertion of temporary bladder tube | 11 | $566 | $51 |
| Manual urinalysis test with examination using microscope, automated | 90 | $395 | $4 |
| Automated urinalysis test | 67 | $228 | $3 |
| Urinalysis, manual test | 15 | $55 | $3 |
| Injection, garamycin, gentamicin, up to 80 mg | 35 | $55 | None |
2014: 20 services
| Leuprolide acetate (for depot suspension), 7.5 mg | 19 | $28,513 | None |
| Diagnostic exam of bladder and urethra using an endoscope | 110 | $27,580 | $183 |
| Short return visit (20+ min) | 260 | $22,198 | $58 |
| New patient visit (30+ min) | 203 | $17,939 | $88 |
| Return visit (30+ min) | 74 | $7,165 | $90 |
| Insertion of lower leg neurostimulator electrode | 17 | $6,994 | $115 |
| Biopsy of prostate gland | 19 | $3,625 | $191 |
| Ultrasound scan of pelvic region through rectum | 33 | $3,047 | $92 |
| Ultrasound measurement of bladder capacity after voiding | 132 | $3,014 | $19 |
| New patient visit (45+ min) | 16 | $2,124 | $133 |
| Complicated insertion of bladder tube | 15 | $2,095 | $116 |
| Ultrasonic guidance for needle placement | 20 | $1,794 | $72 |
| Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | 18 | $1,241 | $32 |
| Simple insertion of temporary bladder tube | 11 | $1,178 | $59 |
| Injection of drug or substance under skin or into muscle | 29 | $896 | $25 |
| Simple bladder irrigation and/or instillation | 16 | $747 | $42 |
| Urinalysis, manual test | 36 | $140 | $3 |
| Manual urinalysis test with examination using microscope, automated | 16 | $68 | $4 |
| Injection, garamycin, gentamicin, up to 80 mg | 30 | $36 | None |
| Automated urinalysis test | 11 | $33 | $3 |
2013: 17 services
| Diagnostic exam of bladder and urethra using an endoscope | 115 | $26,873 | $184 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 19 | $24,077 | None |
| Short return visit (20+ min) | 208 | $18,741 | $59 |
| New patient visit (30+ min) | 150 | $12,721 | $85 |
| New patient visit (45+ min) | 61 | $8,185 | $134 |
| Return visit (30+ min) | 76 | $7,668 | $94 |
| Complicated insertion of bladder tube | 18 | $4,378 | $109 |
| Ultrasonic guidance for needle placement | 15 | $3,424 | $214 |
| Ultrasound measurement of bladder capacity after voiding | 107 | $2,971 | $19 |
| Biopsy of prostate gland | 14 | $2,357 | $168 |
| Ultrasound scan of pelvic region through rectum | 21 | $1,506 | $72 |
| Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | 20 | $1,239 | $33 |
| Insertion of stent in ureter using an endoscope | 13 | $1,217 | $81 |
| Simple bladder irrigation and/or instillation | 21 | $1,065 | $46 |
| Injection of drug or substance under skin or into muscle | 25 | $773 | $26 |
| Urinalysis, manual test | 35 | $145 | $3 |
| Injection, garamycin, gentamicin, up to 80 mg | 29 | $30 | None |
Money from drug and device companies
$129 in 2020
A payment is not proof that care is biased.
| Pfizer | Xtandi | $116 | 1 payment
|
| Novo Nordisk | Ozempic | $13 | 1 payment
|
See all 2 published payments
| Novo Nordisk | Meals · 2020-05-11 | Ozempic | $13 |
| Pfizer | Meals · 2020-02-12 | Xtandi | $116 |
Professional record
- NPI
- 1093817819
- Licence
- CA A46519California A46519: Current · expires 2028-10-31
- Trained
- University of Arizona College of Medicine, 1982
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Urology (208800000X)
- Mailing address
- 2350 W El Camino Real, 2nd Floor, Mountain View, CA, 94040
- NPI first listed
- 2006-09-02
- NPI last updated
- 2012-01-04
This is when the NPI record was last certified, not a medical board exam.